๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Transient Ischemic Attack (TIA)
Clinical trial register · China

Transient Ischemic Attack (TIA) Trials in China

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19029 matching records held by the registry are in this view. Synced 20 Sep 2026, 17:51 UTC
19029
Studies in scope
all four open statuses
11774
Recruiting now
open to new participants
2008
Lead sponsors
across recruiting studies
Top sites
Beijing 2 Shihezi 1
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing2 Shihezi1
All 2 locations
Target enrolment
to
2 of 19029 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China
NCT07143149Ischemic Stroke, Transient Ischemic Attack (TIA)
Beijing Tiantan Hospital
Not applicable
4,000
Beijing
2025-11-03
Recruiting
Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System
NCT06783049Ischemic Stroke, Transient Ischemic Attack (TIA)
Beijing Tiantan Hospital
Not applicable
4,490
Beijing, Shihezi
2025-03-03
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-china/condition/transient-ischemic-attack-tia

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.